[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$54share Graphic](https://lunarcrush.com/gi/w:26/t:$54share.png) $54share

New developments are sparking excitement within the community. However, market volatility is causing some concern among investors.

### About $54share
A cryptocurrency or digital asset.  

### Insights [#](/topic/$54share/insights)
- $54share mentions hit X which is XXX% higher than it's daily average.
- $54share creators hit X which is XXX% higher than it's daily average.
- $54share Creators hit a 52-Week high of XX for the day
- $54share Creators hit an all time of XX for the day
- $54share Mentions hit a 52-Week high of XX for the day
- $54share Mentions hit an all time of XX for the day

### Engagements: XXX [#](/topic/$54share/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$54share/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$54share/time-series/interactions.tsv)  
**Current Value**: XXX  
**Daily Average**: XXX  
**1 Week**: XXXXX -XX%  
**1 Month**: XXX -XX%  
**1-Year High**: XXXXX on 2025-08-01  
**1-Year Low**: X on 2025-06-14  

| Social Network | X   |
| -------------- | -   |
| Engagements    | XXX |
  

  
  
### Mentions: X [#](/topic/$54share/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$54share/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$54share/time-series/posts_active.tsv)  
**Current Value**: X  
**Daily Average**: X  
**1-Year High**: XX on 2025-10-15  
**1-Year Low**: X on 2025-05-28  

| Social Network | X  |
| -------------- | -  |
| Mentions       | XX |
  

  
  
### Creators: X [#](/topic/$54share/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$54share/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$54share/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $54share in the last XX hours which is up XX% from X in the previous XX hours
**Daily Average**: X  
**1-Year High**: XX on 2025-10-15  
**1-Year Low**: X on 2025-05-28  

The most influential creators that mention $54share in the last XX hours

| Creator                                    | Rank | Followers | Posts | Engagements |
| -------                                    | ---- | --------- | ----- | ----------- |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ) | X    | XXXXXX    | X     | XX          |

[View More](/list/creators/$54share/100)
  
  
### Sentiment: XX% [#](/topic/$54share/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$54share/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$54share/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -XX%  
**1-Year High**: XX% on 2025-10-15  
**1-Year Low**: XX% on 2025-10-16  

**Most Supportive Themes**
- **Community Engagement:** (45%) Positive sentiment around the project's community involvement and updates.
- **Technological Advancements:** (30%) Enthusiasm for new features and technological progress.
  
**Most Critical Themes**
- **Market Volatility:** (15%)  Concerns about the overall market conditions and their impact.
- **Competition:** (10%)  Discussion about competing projects and their potential impact.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %   |
| ------- | -------- | -   | ------- | -   | -------- | -   |
| X       | XX       | XX% | XX      | XX% | XX       | XX% |
|         |          |     |         |     |          |     |
| Total   | XX       | XX% | XX      | XX% | XX       | XX% |
  


**Top assets mentioned**
In the posts about $54share in the last XX hours

[Akero Therapeutics, Inc. Common Stock (AKRO)](/topic/akro-akero-therapeutics-inc)
[Akropolis (AKRO)](/topic/$akro)
[Novo-Nordisk (NVO)](/topic/$nvo)
[Johnson & Johnson (JNJ)](/topic/johnson-johnson)
[Johnson & Johnson (JNJ)](/topic/$jnj)
[Rayonier Inc. (RYN)](/topic/$ryn)
[PotlatchDeltic Corporation Common Stock (PCH)](/topic/$pch)
[Novartis AG (NVS)](/topic/novartis)

**Top topics mentioned**
In the posts about $54share in the last XX hours

[akro akero therapeutics inc](/topic/akro-akero-therapeutics-inc), [stocks healthcare](/topic/stocks-healthcare), [$akro](/topic/$akro), [$novcde](/topic/$novcde), [$nvo](/topic/$nvo), [$52b](/topic/$52b), [acquisition](/topic/acquisition), [novo](/topic/novo), [$6share](/topic/$6share), [johnson johnson](/topic/johnson-johnson), [$jnj](/topic/$jnj), [$ryn](/topic/$ryn), [$pch](/topic/$pch), [$47b](/topic/$47b), [novartis](/topic/novartis), [$telo](/topic/$telo), [$ngne](/topic/$ngne), [$cdtx](/topic/$cdtx), [sits](/topic/sits), [$etnb](/topic/$etnb), [marks](/topic/marks), [jan](/topic/jan), [fell](/topic/fell)

### Top Social Posts [#](/topic/$54share/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Key moves from todays filings: -Spin-off: $JNJ to separate its Orthopaedics business into standalone DePuy Synthes within 18-24 months -Merger Arb: $RYN/$PCH agree to $8.2B all-stock merger XXXXXX Rayonier shares per PCH share (8.25% premium) -Merger Arb: $AKRO to be acquired by Novo Nordisk for $54/share plus $6/share CVR (total $5.2B) -Allegation: $JEF addressed fraud allegations related to Point Bonita Capitals exposure in First Brands Group -CEO Change: $VMC names Ronnie A. Pruitt next CEO; $PRIM appoints Koti Vadlamudi as CEO Full details in thread below"  
[X Link](https://x.com/catalyst8kio/status/1978390416111345805) [@catalyst8kio](/creator/x/catalyst8kio) 2025-10-15T09:20Z XX followers, XX engagements


"$ETNB competitor developing a MASH treatment $AKRO was just acquired by $NVO. Big pharma is clearly betting heavily on these drugs. Theres also an interesting CVR component attached to the AKRO deal. The offer is for $54/share in cash + $6/share in CVR and the stock currently trades at $54.08/share. The CVR payout is tied to the cirrhosis indication approval as well but with much stronger upside than in the case of ETNB. I havent looked into this in detail yet but its worth checking out"  
[X Link](https://x.com/InvestSpecial/status/1976643630484869147) [@InvestSpecial](/creator/x/InvestSpecial) 2025-10-10T13:39Z 31K followers, 5818 engagements


"Akero Therapeutics $AKRO +19% surges on $5.2B Novo Nordisk acquisition deal $54/share cash plus $X if MASH drug approved. Closes by year-end. @jonnajarian @petenajarian #ITSNOTANOPTION 📙"  
[X Link](https://x.com/MarketRebels/status/1976350699479879730) [@MarketRebels](/creator/x/MarketRebels) 2025-10-09T18:15Z 354.3K followers, 6525 engagements


"📣 Biotech Stock News 10/09 @ Open $TELO XX% Discovery of Telomir-1 in Cancer Cells $AKRO XX% Acquisition for up to $XXX Billion $NGNE XX% Positive Regulatory Update for NGN-401 $CDTX XX% FDA Breakthrough Therapy Designation for CD388 $APGE X% Pricing of $XXX Million Offering $SXTP X% Unveils Chronic Babesiosis Clinical Trial $ANVS X% Novel Biomarker Data in Alzheimer's $WGS X% Launch of Autism Partnership Program $PTHS X% Launches Moms Against Molluscum Movement $ADIL X% Partners for Precision Medicine Testing $CPRX X% Presentations at Upcoming Scientific Conferences $AMIX X% U.S. Patent for"  
[X Link](https://x.com/BiopharmIQ/status/1976314440908931409) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-09T15:50Z 27.4K followers, 9824 engagements